CtNorm: Actual time PCR cycle of threshold (Ct) normalization algorithm
In relative quantification with Actual Time PCR (qRT-PCR,), correct evaluation requires equal amplification effectivity for each genes (Gene of curiosity and reference gene) and equal threshold values for all of the samples. On this quantification technique the expression stage in handled samples shall be calculated compared to the management group. We carried out the current examine to design an algorithm for changing the info obtained from totally different runs containing similar customary samples into one run with the identical amplification effectivity and threshold worth.
For this goal, two formulation have been designed; one to transform the amplification effectivity of the every run to 100%, and the opposite one for changing knowledge from totally different runs into one run. Using these two formulation, an algorithm was developed and named CtNorm. The web model of CtNorm algorithm is on the market at http://ctnorm.sums.ac.ir/. We used qRT-PCR method to validate the accuracy of the designed algorithm for the normalization of 4 totally different human inside management genes.
Normalizing the Ct values obtained from separate runs with the CtNorm algorithm has eradicated the variations and the common of the Ct values has change into much like the situation during which all of the samples have been amplified in a single run. The CtNorm algorithm could possibly be utilized for equalizing the Ct values of a number of qRT-PCR runs with the identical customary samples. The algorithm has additionally the flexibility to transform the amplification effectivity to 100% which is helpful in absolute and relative quantification.
cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Corpus |
|||
| C1534276 | Biochain | 40 reactions | EUR 578 |
cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Fundus |
|||
| C1534278 | Biochain | 40 reactions | EUR 578 |
cDNA - Monkey (Cynomolgus) Normal Tissue: Uterus: Cervix |
|||
| C1534275-Cy | Biochain | 40 reactions | EUR 578 |
Total RNA - Human Adult Normal Tissue: Uterus: Cervix of uterus |
|||
| R1234275-50 | Biochain | 50 ug | EUR 170 |
Total RNA - Human Adult Normal Tissue: Uterus: Corpus of Uterus |
|||
| R1234276-10 | Biochain | 10 ug | EUR 191 |
Fetal Uterus Lysate |
|||
| XBL-10431 | ProSci | 0.1 mg | EUR 632.4 |
|
Description: Fetal human uterus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human uterus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the uterus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The uterus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Uterus Membrane Lysate |
|||
| XBL-11023 | ProSci | 0.1 mg | EUR 619.8 |
|
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Rat Uterus Fibroblasts |
|||
| ABC-TC4237 | AcceGen | 1 vial | Ask for price |
|
Description: Rat uterus fibroblasts, 6-week Wistar rat |
|||
OORA00351-10U - UTERUS |
|||
| OORA00351-10U | Aviva Systems Biology | 1Each | EUR 105 |
OORA00351-1EA - UTERUS |
|||
| OORA00351-1EA | Aviva Systems Biology | 1Each | EUR 99 |
OORA00493-10U - UTERUS |
|||
| OORA00493-10U | Aviva Systems Biology | 1Each | EUR 55 |
OORA00493-1EA - UTERUS |
|||
| OORA00493-1EA | Aviva Systems Biology | 1Each | EUR 59 |
Bovine UTERUS 5 EA* |
|||
| 57153-2 | Pel-Freez | 5 EA | EUR 245.04 |
Total RNA - Lupus: Uterus |
|||
| R1236274Lup-50 | Biochain | 50 ug | EUR 421.2 |
Total RNA - Human Adult Normal Tissue 5 Donor Pool: Uterus: Cervix of uterus |
|||
| R1234275-P | Biochain | 50 ug | EUR 370 |
Human Uterus Tumor lysate |
|||
| HTL-1384 | Alpha Diagnostics | 1 mg | EUR 927.6 |
OORA00552-1U - Rat UTERUS |
|||
| OORA00552-1U | Aviva Systems Biology | 1Each | EUR 60 |
Uterus tumor tissue array |
|||
| UT802a | TissueArray | each | EUR 306 |
|
Description: Uterus tumor tissue array, including stromal and leiomyo sarcoma, endometrioid adenocarcinoma, chorionepithelioma, hydatidiform mole, clear cell carcinoma, carcinsarcoma, sarcomatoid carcinoma, with pathology grade, TNM/Stage (AJCC 8th edition), 80 cases/80 cores (cores size 1.5mm), replacing UT802 |
|||
Uterus Tissue Slide (Normal) |
|||
| 11-401-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Normal) |
|||
| 11-401-4um | ProSci | 4 um | EUR 216.6 |
Uterus Tissue Slide (Benign) |
|||
| 11-402-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Benign) |
|||
| 11-402-4um | ProSci | 4 um | EUR 216.6 |
OORA00552-1EA - Rat UTERUS |
|||
| OORA00552-1EA | Aviva Systems Biology | 1Each | EUR 59 |
Human Uterus Tissue Lysate |
|||
| IHUUTETL100UG | Innovative research | each | EUR 245 |
|
Description: Human Uterus Tissue Lysate |
|||
Rabbit UTERUS Y 25 EA* |
|||
| 41253-2 | Pel-Freez | 25 EA | EUR 382.07 |
Uterus Tissue Slide (Abnormal) |
|||
| 11-419-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Abnormal) |
|||
| 11-419-4um | ProSci | 4 um | EUR 216.6 |
Uterus Membrane Tumor Lysate |
|||
| XBL-11031 | ProSci | 0.1 mg | EUR 752.1 |
|
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
OORA00523-1U - Rabbit UTERUS |
|||
| OORA00523-1U | Aviva Systems Biology | 1Each | EUR 255 |
OORA00523-1EA - Rabbit UTERUS |
|||
| OORA00523-1EA | Aviva Systems Biology | 1Each | EUR 239 |
Uterus Tissue Slide (Adenomyoma) |
|||
| 11-432-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Adenomyoma) |
|||
| 11-432-4um | ProSci | 4 um | EUR 216.6 |
OORA00470-10U - Hamster UTERUS |
|||
| OORA00470-10U | Aviva Systems Biology | 1Each | EUR 75 |
OORA00470-1EA - Hamster UTERUS |
|||
| OORA00470-1EA | Aviva Systems Biology | 1Each | EUR 69 |
Uterus-Corpus Membrane Lysate |
|||
| XBL-11037 | ProSci | 0.1 mg | EUR 619.8 |
|
Description: Human uterus-corpus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-corpus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-corpus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-corpus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Uterus-Fundus Membrane Lysate |
|||
| XBL-11040 | ProSci | 0.1 mg | EUR 619.8 |
|
Description: Human uterus-fundus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-fundus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-fundus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-fundus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
OCPB00133-100UG - Uterus Lysate |
|||
| OCPB00133-100UG | Aviva Systems Biology | 0.1mg | EUR 139 |
Uterus Tissue Slide (Adenocarcinoma) |
|||
| 11-404-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Adenocarcinoma) |
|||
| 11-404-4um | ProSci | 4 um | EUR 216.6 |
Uterus cancer test tissue array |
|||
| T093 | TissueArray | each | EUR 78 |
|
Description: Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores |
|||
Leiomyoma of uterus tissue array |
|||
| SO806 | TissueArray | each | EUR 270 |
|
Description: Leiomyoma of uterus tissue array, 80 cases/80 cores |
|||
Human Uterus Fetal Tissue Lysate |
|||
| IHUUTEFSTL100UG | Innovative research | each | EUR 1133 |
|
Description: Human Uterus Fetal Tissue Lysate |
|||
Human Uterus Tumor Tissue Lysate |
|||
| IHUUTETLT100UG | Innovative research | each | EUR 361 |
|
Description: Human Uterus Tumor Tissue Lysate |
|||
OORA00440-10U - GUINEA PIG UTERUS |
|||
| OORA00440-10U | Aviva Systems Biology | 1Each | EUR 80 |
OORA00440-1EA - GUINEA PIG UTERUS |
|||
| OORA00440-1EA | Aviva Systems Biology | 1Each | EUR 79 |
OCPB00611-100UG - Fetal Uterus Lysate |
|||
| OCPB00611-100UG | Aviva Systems Biology | 0.1mg | EUR 579 |
OCPB00088-100UG - Uterus Tumor Lysate |
|||
| OCPB00088-100UG | Aviva Systems Biology | 0.1mg | EUR 199 |
Human Uterus Lysate Membrane Fraction |
|||
| IHUUTETLM100UG | Innovative research | each | EUR 870 |
|
Description: Human Uterus Lysate Membrane Fraction |
|||
Total RNA - Human Tumor Tissue: Uterus |
|||
| R1235274-50 | Biochain | 50 ug | EUR 400 |
OCPB00744-100UG - Uterus Membrane Lysate |
|||
| OCPB00744-100UG | Aviva Systems Biology | 0.1mg | EUR 559 |
Uterus Tissue Slide (Spindle Cell Tumor) |
|||
| 11-418-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Spindle Cell Tumor) |
|||
| 11-418-4um | ProSci | 4 um | EUR 216.6 |
Total Protein - Human Tumor Tissue: Uterus |
|||
| P1235274 | Biochain | 1 mg | EUR 310 |
Frozen Tissue Section - Human Tumor: Uterus |
|||
| T1235274 | Biochain | 5 slides | EUR 330 |
Innovative Grade US Origin Bovine Uterus |
|||
| IGBOUTEF | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGBOUTEP | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGBOUTES | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGBOUTEZ | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGCLFUTEF | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGCLFUTEP | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGCLFUTES | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGCLFUTEZ | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGMBOUTEF | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGMBOUTEP | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGMBOUTES | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Bovine Uterus |
|||
| IGMBOUTEZ | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEFT1 | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEFT2 | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEFT3 | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEFT4 | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEPT1 | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEPT2 | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEPT3 | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEPT4 | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEST1 | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEST2 | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEST3 | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEST4 | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEZT1 | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEZT2 | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEZT3 | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Innovative Grade US Origin Porcine Uterus |
|||
| IGPCUTEZT4 | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Porcine Uterus |
|||
Membrane Protein - Human Tumor Tissue: Uterus |
|||
| P3235274 | Biochain | 0.1 mg | EUR 410 |
Uterus Tissue Slide (Endometrioid Adenocarcinoma) |
|||
| 11-405-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide (Endometrioid Adenocarcinoma) |
|||
| 11-405-4um | ProSci | 4 um | EUR 216.6 |
Human Uterus Tumor Lysate Membrane Fraction |
|||
| IHUUTETLTM100UG | Innovative research | each | EUR 1199 |
|
Description: Human Uterus Tumor Lysate Membrane Fraction |
|||
Human Uterus Corpus Lysate Membrane Fraction |
|||
| IHUUTCTLM100UG | Innovative research | each | EUR 870 |
|
Description: Human Uterus Corpus Lysate Membrane Fraction |
|||
Human Uterus Fundus Lysate Membrane Fraction |
|||
| IHUUTFTLM100UG | Innovative research | each | EUR 870 |
|
Description: Human Uterus Fundus Lysate Membrane Fraction |
|||
FFPE Genomic DNA - Human Tumor Tissue: Uterus |
|||
| D2235274 | Biochain | 2 ug | EUR 960 |
Total RNA - Human Adult Normal Tissue: Uterus |
|||
| R1234274-50 | Biochain | 50 ug | EUR 170 |
OCPB00746-100UG - Uterus Membrane Tumor Lysate |
|||
| OCPB00746-100UG | Aviva Systems Biology | 0.1mg | EUR 689 |
Monkey (Cyno.) Normal Uterus Whole tissue lysate |
|||
| MCL-1222 | Alpha Diagnostics | 1 mg | EUR 927.6 |
Human Adult Uterus (Normal) Whole tissue lysate |
|||
| HAL-1317 | Alpha Diagnostics | 1 mg | EUR 628.8 |
OCPB00747-100UG - Uterus-Corpus Membrane Lysate |
|||
| OCPB00747-100UG | Aviva Systems Biology | 0.1mg | EUR 559 |
OCPB00748-100UG - Uterus-Fundus Membrane Lysate |
|||
| OCPB00748-100UG | Aviva Systems Biology | 0.1mg | EUR 559 |
Total Protein - Human Adult Normal Tissue: Uterus |
|||
| P1234274 | Biochain | 1 mg | EUR 188 |
Monkey (Rhesus) Normal Uterus Whole tissue lysate |
|||
| MRL-1332 | Alpha Diagnostics | 1 mg | EUR 927.6 |
Frozen Tissue Section - Human Adult Normal: Uterus |
|||
| T1234274 | Biochain | 5 slides | EUR 343 |
Uterus Tissue Slide ( Papillary serous Adenocarcinoma) |
|||
| 11-407-10um | ProSci | 10 um | EUR 241.8 |
Uterus Tissue Slide ( Papillary serous Adenocarcinoma) |
|||
| 11-407-4um | ProSci | 4 um | EUR 216.6 |
Genomic DNA - Lupus: Uterus, from a single donor |
|||
| D1236274Lup | Biochain | 50 ug | EUR 504 |
Human Uterus Tissue Slide (Normal) (5 slides/pk) |
|||
| HTS-11401 | Alpha Diagnostics | 1 pk | EUR 343.2 |
Human Uterus Tissue Slide (Benign) (5 slides/pk) |
|||
| HTS-11402 | Alpha Diagnostics | 1 pk | EUR 343.2 |
Membrane Protein - Human Adult Normal Tissue: Uterus |
|||
| P3234274 | Biochain | 0.1 mg | EUR 270 |
Paraffin Tissue Section - Human Adult Normal: Uterus |
|||
| T2234274 | Biochain | 5 slides | EUR 185 |
Paraffin Tissue Section - Human Uterus Cervix Tumor |
|||
| T2235275 | Biochain | 5 slides | EUR 238 |
Human Uterus Tissue Slide (Abnormal) (5 slides/pk) |
|||
| HTS-11419 | Alpha Diagnostics | 1 pk | EUR 343.2 |
Human Uterus Tissue Slide (Adenomyoma) (5 slides/pk) |
|||
| HTS-11432 | Alpha Diagnostics | 1 pk | EUR 343.2 |
Total Protein - Human Adult Normal Tissue: Uterus: Cervix |
|||
| P1234275 | Biochain | 1 mg | EUR 188 |
Total Protein - Human Adult Normal Tissue: Uterus: Corpus |
|||
| P1234276 | Biochain | 1 mg | EUR 188 |
Total Protein - Human Adult Normal Tissue: Uterus: Fundus |
|||
| P1234278 | Biochain | 1 mg | EUR 188 |
Human Uterus Tissue Slide (Adenocarcinoma) (5 slides/pk) |
|||
| HTS-11404 | Alpha Diagnostics | 1 pk | EUR 343.2 |
Multiple of uterus cancer with endometrium tissue array |
|||
| UT1501a | TissueArray | each | EUR 258 |
|
Description: Multiple of uterus cancer with endometrium tissue array, including pathology grade, TNM and clinical stage, 75 cases/150 cores, replacing UT1501 |
|||
Rat Normal Uterus (5 slides/pack, single section/slide) |
|||
| S-RaFPT041 | TissueArray | 1 unit | EUR 95 |
Membrane Protein - Human Adult Normal Tissue: Uterus: Corpus |
|||
| P3234276 | Biochain | 0.1 mg | EUR 270 |
Membrane Protein - Human Adult Normal Tissue: Uterus: Fundus |
|||
| P3234278 | Biochain | 0.1 mg | EUR 270 |
Normal Human Uterus (5 slides/pack, single section/slide) |
|||
| S-HuFPT096 | TissueArray | 1 unit | EUR 95 |
Mouse Normal Uterus (5 slides/pack, single section/slide) |
|||
| S-MoFPT046 | TissueArray | 1 unit | EUR 95 |
Total RNA - Human Adult Normal Tissue 5 Donor Pool: Uterus |
|||
| R1234274-P | Biochain | 50 ug | EUR 370 |
Paraffin Tissue Section - Human Uterus Tumor: Adenocarcinoma, MSS |
|||
| T2235274MSS | Biochain | 5 slides | EUR 524 |
Human Uterus Tissue Slide (Spindle cell tumor) (5 slides/pk) |
|||
| HTS-11418 | Alpha Diagnostics | 1 pk | EUR 343.2 |
Rat Normal Uterus (single section per slide) (5 slides/pack) |
|||
| RaFPT041 | TissueArray | 5 slides | EUR 150 |
Cynomolgus Monkey: Uterus (5 slides/pack, single section/slide) |
|||
| S-CyFPT081 | TissueArray | 1 unit | EUR 95 |
Innovative Grade US Origin Bovine Uterus with Placenta Intact |
|||
| IGBOUTEPLCF | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus with Placenta Intact |
|||
Innovative Grade US Origin Bovine Uterus with Placenta Intact |
|||
| IGBOUTEPLCP | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus with Placenta Intact |
|||
Innovative Grade US Origin Bovine Uterus with Placenta Intact |
|||
| IGBOUTEPLCS | Innovative research | each | EUR 210 |
|
Description: Innovative Grade US Origin Bovine Uterus with Placenta Intact |
|||
Innovative Grade US Origin Bovine Uterus with Placenta Intact |
|||
| IGBOUTEPLCZ | Innovative research | each | EUR 133 |
|
Description: Innovative Grade US Origin Bovine Uterus with Placenta Intact |
|||
Normal Human Uterus (single section per slide) (5 slides/pack) |
|||
| HuFPT096 | TissueArray | 5 slides | EUR 150 |
Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV positive |
|||
| T2235275HPV+ | Biochain | 5 slides | EUR 646.8 |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
|||
Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV negative |
|||
| T2235275HPV- | Biochain | 5 slides | EUR 646.8 |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
|||
Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV negative |
|||
| T2235275HPV-negative | Biochain | 5 slides | EUR 524 |
Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV positive |
|||
| T2235275HPV-positive | Biochain | 5 slides | EUR 524 |
Paraffin Tissue Section - Human Uterus Cervix Tumor, HPV positive |
|||
| T2235275HPV | Biochain | 5 slides | EUR 550 |
Normal Rhesus Monkey Uterus (5 slides/pack, single section/slide) |
|||
| S-RsFPT156 | TissueArray | 1 unit | EUR 95 |
Paraffin Tissue Section - Human Uterus Tumor: Endometrium Adenocarcinoma |
|||
| T2235274-3 | Biochain | 5 slides | EUR 238 |
Human Uterus Tissue Slide (Endometrioid Adenocarcinoma) (5 slides/pk) |
|||
| HTS-11405 | Alpha Diagnostics | 1 pk | EUR 343.2 |
Cynomolgus Monkey: Uterus (single section per slide) (5 slides/pack) |
|||
| CyFPT081 | TissueArray | 5 slides | EUR 150 |
Genomic DNA - Human Tumor Tissue: Uterus Tumor, from a single donor |
|||
| D1235274 | Biochain | 50 ug | EUR 489 |
Uterus Tissue Slides, Normal Human Paraffin Sections, 5 slides/pack |
|||
| TS-H5025 | IHC World | - | EUR 145 |
Genomic DNA - Human Adult Normal Tissue: Uterus, from a single donor |
|||
| D1234274 | Biochain | 100 ug | EUR 286 |
Human Uterus Tissue Slide (Papillary serous Adenocarcinoma) (5 slides/pk) |
|||
| HTS-11407 | Alpha Diagnostics | 1 pk | EUR 343.2 |
Genomic DNA - Human Adult Normal Tissue: Uterus: Cervix, from a single donor |
|||
| D1234275 | Biochain | 100 ug | EUR 286 |
Multiple Tumor Tissue Array - Bladder, Colon, Kidney, Lung, Stomach, and Uterus tumors |
|||
| T8235716d-2 | Biochain | 2 slides | EUR 295 |
(untagged)-Human cDNA FLJ40947 fis, clone UTERU2009538 |
|||
| SC126972 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ36683 fis, clone UTERU2007924 |
|||
| SC102185 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ36761 fis, clone UTERU2018884 |
|||
| SC102190 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ41014 fis, clone UTERU2018674 |
|||
| SC102214 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ36681 fis, clone UTERU2006547 |
|||
| SC103740 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40933 fis, clone UTERU2007081 |
|||
| SC312171 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40948 fis, clone UTERU2009540 |
|||
| SC312591 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ36760 fis, clone UTERU2018867 |
|||
| SC313963 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40929 fis, clone UTERU2006705 |
|||
| SC311639 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40923 fis, clone UTERU2006400 |
|||
| SC311706 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40930 fis, clone UTERU2006899 |
|||
| SC311919 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40961 fis, clone UTERU2011811 |
|||
| SC311996 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40938 fis, clone UTERU2007639 |
|||
| SC312097 | Origene Technologies GmbH | 10 µg | Ask for price |
Multiple Tumor Tissue Array - Ovary, Bladder, Breast, Kidney, Uterus, and Lung tumors, plus 12 tumor/normal pairs |
|||
| T8235714d-2 | Biochain | 2 slides | EUR 295 |
Multiple Tumor Tissue Array - Ovary, Bladder, Breast, Kidney, Uterus, and Lung tumors, plus 12 tumor/normal pairs |
|||
| T8235714d-5 | Biochain | 5 slides | EUR 606 |
Multiple Tumor Tissue Array - Bladder, Colon, Kidney, Lung, Stomach, and Uterus tumors, plus 12 tumor/normal pairs |
|||
| T8235716d-5 | Biochain | 5 slides | EUR 606 |
(untagged)-Human cDNA FLJ36708 fis, clone UTERU2009904, moderately similar to ZINC TRANSPORTER 2 |
|||
| SC312753 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ33143 fis, clone UTERU2000047, weakly similar to Human neuropilin-2(a0) mRNA |
|||
| SC312285 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40950 fis, clone UTERU2009972, moderately similar to Human mRNA for SPIN protein |
|||
| SC105026 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40934 fis, clone UTERU2007128, highly similar to Spondyloepiphyseal dysplasia, late |
|||
| SC311789 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ40957 fis, clone UTERU2011574, moderately similar to Human PMS2 related (hPMSR3) gene |
|||
| SC127025 | Origene Technologies GmbH | 10 µg | Ask for price |
(untagged)-Human cDNA FLJ33137 fis, clone UTERU1000077, moderately similar to GAMETOGENESIS EXPRESSED PROTEIN GEG-154 |
|||
| SC311795 | Origene Technologies GmbH | 10 µg | Ask for price |
MMP7 (untagged)-Human matrix metalloproteinase 7 (matrilysin, uterine), mRNA (cDNA clone MGC:3913 IMAGE:3545760), complete cds |
|||
| SC126089 | Origene Technologies GmbH | 10 µg | Ask for price |
SCGB1A1 (untagged)-Human secretoglobin, family 1A, member 1 (uteroglobin), mRNA (cDNA clone MGC:10583 IMAGE:3688615), complete cds |
|||
| SC126071 | Origene Technologies GmbH | 10 µg | Ask for price |
Cat Catalase, CAT GENLISA ELISA |
|||
| KLT0069 | Krishgen | 1 x 96 wells | EUR 341 |
CAT (untagged)-Human catalase (CAT) |
|||
| SC119081 | Origene Technologies GmbH | 10 µg | Ask for price |
CAT/ Rat CAT ELISA Kit |
|||
| ELA-E0242r | Lifescience Market | 96 Tests | EUR 1063.2 |
CAT |
|||
| enz-629 | ProSpec Tany | 5µg | EUR 60 |
|
Description: Recombinant Human Catalase |
|||
Cat (GFP-tagged) - Mouse catalase (Cat) |
|||
| MG208453 | Origene Technologies GmbH | 10 µg | Ask for price |
CAT (GFP-tagged) - Human catalase (CAT) |
|||
| RG210763 | Origene Technologies GmbH | 10 µg | Ask for price |
Cat (untagged) - Mouse catalase (Cat), (10ug) |
|||
| MC205746 | Origene Technologies GmbH | 10 µg | Ask for price |
CAT (Myc-DDK-tagged)-Human catalase (CAT) |
|||
| RC210763 | Origene Technologies GmbH | 10 µg | Ask for price |
Cat (Myc-DDK-tagged) - Mouse catalase (Cat) |
|||
| MR208453 | Origene Technologies GmbH | 10 µg | Ask for price |
cDNA - Plant Normal Tissue: cDNA - Plant: Corn |
|||
| C1634330 | Biochain | 40 reactions | EUR 674 |
cDNA - Plant Normal Tissue: cDNA - Plant: Rice |
|||
| C1634360 | Biochain | 40 reactions | EUR 674 |
cDNA - Plant Normal Tissue: cDNA - Plant: Wheat |
|||
| C1634390 | Biochain | 40 reactions | EUR 674 |
cDNA - Plant Normal Tissue: cDNA - Plant: Orange |
|||
| C1634340 | Biochain | 40 reactions | EUR 674 |
cDNA - Plant Normal Tissue: cDNA - Plant: Potato |
|||
| C1634350 | Biochain | 40 reactions | EUR 674 |
Cat IgM |
|||
| 31C-CH0213 | Fitzgerald | 1 mg | EUR 470.4 |
|
Description: Purified Cat IgM |
|||
Cat CRP |
|||
| 8104 | Life Diagnostics | 0.1 mg | EUR 220 |
Cat SAA |
|||
| 9004 | Life Diagnostics | 0.1 mg | EUR 500 |
Cat LRG1 |
|||
| 9060 | Life Diagnostics | 0.1 mg | EUR 500 |
Cat NGAL |
|||
| NGAL-8-0.05 | Life Diagnostics | 50 μg | EUR 300 |
CAT siRNA |
|||
| 20-abx910366 | Abbexa |
|
|
CAT siRNA |
|||
| 20-abx910367 | Abbexa |
|
|
CAT siRNA |
|||
| 20-abx900807 | Abbexa |
|
|
pCas9- CAT |
|||
| PVT11001 | Lifescience Market | 2 ug | EUR 361.2 |
cDNA - Plant Normal Tissue: cDNA - Plant: Arabidopsis |
|||
| C1634310 | Biochain | 40 reactions | EUR 674 |
CAT antibody |
|||
| 10R-3584 | Fitzgerald | 100 ul | EUR 871.2 |
|
Description: Mouse monoclonal CAT antibody |
|||
CAT antibody |
|||
| 10R-3585 | Fitzgerald | 100 ul | EUR 829.2 |
|
Description: Mouse monoclonal CAT antibody |
|||
CAT antibody |
|||
| 20C-CR1111RP | Fitzgerald | 500 ul | EUR 314.4 |
|
Description: Rabbit polyclonal CAT antibody |
|||
CAT antibody |
|||
| 70R-16187 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal CAT antibody |
|||
CAT Antibody |
|||
| 36312-100ul | SAB | 100ul | EUR 302.4 |
CAT Antibody |
|||
| 1-CSB-PA004563GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against CAT. Recognizes CAT from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
CAT Antibody |
|||
| 1-CSB-PA004980 | Cusabio |
|
|
|
Description: A polyclonal antibody against CAT. Recognizes CAT from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
|||
Enchancment of pneumococcal pneumonia prognosis utilizing quantitative real-time PCR concentrating on lytA in grownup sufferers: A potential cohort examine
Aims: The intention of the examine was to evaluate the efficiency of real-time polymerase chain response (PCR) concentrating on the lytA gene (rtPCR-lytA) in plasma, urine and nasopharyngeal (NP) samples for the prognosis of pneumococcal community-acquired pneumonia (P-CAP).
Strategies: Potential observational examine together with all consecutive grownup CAP sufferers from November 2015 to Could 2017. P-CAP was outlined if pneumococcus was recognized utilizing typical strategies (CM) and/or a optimistic rtPCR-lytA was detected in blood, urine or NP samples (NP cut-off ≥8000 copies/mL). Diagnostic efficiency of every check was calculated.
Outcomes: 133 CAP sufferers have been included. Of those, P-CAP was identified in 62 circumstances (46.6%). The proportion of P-CAP identified by rtPCR-lytA strategies was considerably larger than by CM (87.1% vs 59.7%, p=0.005). RtPCR-lytA recognized S. pneumoniae in 25 sufferers (40.3% of all P-CAP circumstances) whose prognosis would have been missed by CM. NP-rtPCR-lytA allowed diagnosing 62.3% of P-CAP. A nasopharyngeal colonisation density ≥2351 copies/mL predicted P-CAP prognosis (AUC=0.82, sensitivity=83.3%, specificity=80.9%). There was a optimistic correlation between growing bacterial load in blood and CURB65 (Spearman correlation coefficient r=0.4, p=0.001), PSI (r=0.3, p=0.02), and time to scientific stability (r=0.33, p=0.01). Median bacterial load in blood was larger in P-CAP sufferers with bacteraemia (0.65×103 vs 0x103 copies/mL, p=0.002), ICU admission (0.68×103 vs 0x103 copies/mL, p=0.04) or mechanical air flow (7.45×103 vs 0x103 copies/mL, p=0.04).
Conclusions: The usage of rtPCR-lytA strategies considerably elevated the prognosis of P-CAP as in comparison with CM. Nasopharyngeal swabs rtPCR-lytA detection, with an correct cut-off worth, was essentially the most promising amongst molecular strategies for the prognosis of P-CAP.
Epidemiology and scientific options of intestinal protozoan infections detected by Actual-Time PCR in non-native kids inside an Italian tertiary care kids’s hospital: a cross-sectional examine
Background: Enteric parasite infections are underestimated because of the restricted sensitivity and specificity of microscopy, which stays the diagnostic gold customary in routine scientific apply. This could possibly be a serious drawback in high-income nations, the place the burden of parasitic illnesses is low. Lately, Multiplex Actual-Time polymerase chain response (RT-PCR) primarily based strategies have been applied. Due to this fact, the intention of this examine was to judge the prevalence of 4 enteric protozoan species detected by RT-PCR in non-native kids in Italy, and to explain their scientific traits.
Strategies: Adopted and immigrant kids, evaluated for migration well being evaluation between 2017 and 2020 in a tertiary care kids’s hospital in Italy, have been enrolled. Molecular evaluation for Giardia lamblia, Dientamoeba fragilis, Blastocystis hominis, and Entamoeba histolytica, was carried out by in-house RT-PCR.
Outcomes: Total, 209 kids have been enrolled and 70% of them resulted optimistic by RT-PCR for no less than one enteric parasite. B. hominis (47.8%) was essentially the most generally recognized protozoa, adopted by D. fragilis (44.5%). Co-infections with a number of pathogens have been detected in 35.4% of the samples. Nearly 80% of parasite-positive kids have been asymptomatic and the most typical symptom was flatulence (60.7% of symptomatic kids). Eosinophils have been considerably elevated in RT-PCR optimistic kids in comparison with the detrimental ones and youngsters with D. fragilis offered the very best eosinophils rely.
Conclusions: The In-house Multiplex RT-PCR assay gives a sound molecular detection system for chosen enteric parasites. This novel and correct diagnostic technique might help in growing the detection price of parasite an infection, particularly in high-risk inhabitants.
Novel common primer-pentaplex PCR assay primarily based on chimeric primers for simultaneous detection of 5 widespread pig viruses related to diarrhea
Viral pathogens related to diarrhea in pigs embody porcine circovirus 2 (PCV2), porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus (TGEV), porcine rotavirus A (RVA) and C (RVC) amongst others. On this examine, a novel common primer-based pentaplex PCR (UP-M-PCR) assay was developed for simultaneous detection and differentiation of those 5 viruses.
The assay makes use of a short-cycle multiplex amplification by chimeric primers (CP), that are virus particular, with a tail added on the 5′ finish of the common primer (UP), adopted by common amplification utilizing UPs and a common cycle amplification. 5 common primers with CPs (UP1-5) have been designed and evaluated in an UP-based single PCR (UP-S-PCR). All 5 UPs have been discovered to work effectively and UP2 exhibited the most effective efficiency.
After system optimizations, the analytical sensitivity of the UP-M-PCR, utilizing plasmids containing the particular viral goal fragments, was 5 copies/response for every of the 5 viruses regardless of presence of a single or a number of viruses within the template. No cross-reaction was noticed with different non-target viruses. When 273 fecal samples from clinically wholesome pigs have been examined, the assay sensitivity was 90.9-100%, the specificity was 98.0-100%, and the settlement price with the UP-S-PCR was 98.5-99.6% with a Kappa worth being 0.95-0.98. In abstract, the UP-M-PCR developed here’s a fast and extremely delicate and particular detection technique that can be utilized to reveal combined infections in pigs with diarrhea.
SLC52A1 Antibody |
|||
| 1-CSB-PA030173 | Cusabio |
|
|
|
Description: A polyclonal antibody against SLC52A1. Recognizes SLC52A1 from Human. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/10000 |
|||
SLC52A1 Antibody |
|||
| E037605 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
SLC52A1 Antibody |
|||
| E40PV7682 | EnoGene | 50ul | EUR 395 |
|
Description: Available in various conjugation types. |
|||
SLC52A1 Antibody (HRP) |
|||
| 20-abx311449 | Abbexa |
|
|
SLC52A1 Antibody (FITC) |
|||
| 20-abx311450 | Abbexa |
|
|
SLC52A1 Antibody (Biotin) |
|||
| 20-abx311451 | Abbexa |
|
|
SLC52A1 Conjugated Antibody |
|||
| C37605 | SAB | 100ul | EUR 476.4 |
SLC52A1 Polyclonal Antibody |
|||
| A67622 | EpiGentek |
|
|
SLC52A1 Antibody, HRP conjugated |
|||
| 1-CSB-PA878904LB01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SLC52A1. Recognizes SLC52A1 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
|||
SLC52A1 Antibody, FITC conjugated |
|||
| 1-CSB-PA878904LC01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SLC52A1. Recognizes SLC52A1 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
|||
OACA06221-50UG - SLC52A1 Antibody |
|||
| OACA06221-50UG | Aviva Systems Biology | 50ug | EUR 179 |
SLC52A1 Antibody, Biotin conjugated |
|||
| 1-CSB-PA878904LD01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against SLC52A1. Recognizes SLC52A1 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
|||
OAAJ06024-100UL - SLC52A1 Antibody |
|||
| OAAJ06024-100UL | Aviva Systems Biology | 100uL | EUR 319 |
OACA06221-100UG - SLC52A1 Antibody |
|||
| OACA06221-100UG | Aviva Systems Biology | 100ug | EUR 319 |
OAAF05202-100UG - SLC52A1 Antibody |
|||
| OAAF05202-100UG | Aviva Systems Biology | 100ug | EUR 329 |
SLC52A1 Polyclonal Antibody, HRP Conjugated |
|||
| A67623 | EpiGentek |
|
|
SLC52A1 Polyclonal Antibody, FITC Conjugated |
|||
| A67624 | EpiGentek |
|
|
SLC52A1 Polyclonal Antibody, Biotin Conjugated |
|||
| A67625 | EpiGentek |
|
|
OASG03143-100UL - SLC52A1 Antibody - middle region |
|||
| OASG03143-100UL | Aviva Systems Biology | 100ul | EUR 239 |
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| 20-abx211053 | Abbexa |
|
|
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| 20-abx211054 | Abbexa |
|
|
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| 20-abx324146 | Abbexa |
|
|
Solute Carrier Family 52 Member 1 (SLC52A1) Antibody |
|||
| 20-abx302068 | Abbexa |
|
|
SLC52A1 siRNA |
|||
| 20-abx934068 | Abbexa |
|
|
Human SLC52A1 shRNA Plasmid |
|||
| 20-abx960440 | Abbexa |
|
|
SLC52A1 Recombinant Protein (Human) |
|||
| RP097485 | ABM | 100 ug | Ask for price |
anti- SLC16A12 antibody |
|||
| FNab07910 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC16A12 |
|||
anti- SLC22A15 antibody |
|||
| FNab07920 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC22A15 |
|||
anti- SLC22A18 antibody |
|||
| FNab07921 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC22A18 |
|||
anti- SLC22A23 antibody |
|||
| FNab07924 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC22A23 |
|||
anti- SLC25A10 antibody |
|||
| FNab07928 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A10 |
|||
anti- SLC25A11 antibody |
|||
| FNab07929 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC25A11 |
|||
anti- SLC25A13 antibody |
|||
| FNab07930 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A13 |
|||
anti- SLC25A15 antibody |
|||
| FNab07931 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A15 |
|||
anti- SLC25A18 antibody |
|||
| FNab07932 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A18 |
|||
anti- SLC25A20 antibody |
|||
| FNab07934 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A20 |
|||
anti- SLC25A22 antibody |
|||
| FNab07935 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A22 |
|||
anti- SLC25A23 antibody |
|||
| FNab07936 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A23 |
|||
anti- SLC25A24 antibody |
|||
| FNab07937 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A24 |
|||
anti- SLC25A25 antibody |
|||
| FNab07938 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A25 |
|||
anti- SLC25A33 antibody |
|||
| FNab07940 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC25A33 |
|||
anti- SLC25A34 antibody |
|||
| FNab07941 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A34 |
|||
anti- SLC25A45 antibody |
|||
| FNab07943 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A45 |
|||
anti- SLC25A46 antibody |
|||
| FNab07944 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A46 |
|||
anti- SLC10A3 antibody |
|||
| FNab07904 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC10A3 |
|||
anti- SLC11A2 antibody |
|||
| FNab07905 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC11A2 |
|||
anti- SLC12A2 antibody |
|||
| FNab07906 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC12A2 |
|||
anti- SLC12A4 antibody |
|||
| FNab07907 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC12A4 |
|||
anti- SLC13A4 antibody |
|||
| FNab07909 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC13A4 |
|||
anti- SLC16A2 antibody |
|||
| FNab07911 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC16A2 |
|||
anti- SLC16A3 antibody |
|||
| FNab07912 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC16A3 |
|||
anti- SLC17A5 antibody |
|||
| FNab07913 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC17A5 |
|||
anti- SLC18A1 antibody |
|||
| FNab07914 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC18A1 |
|||
anti- SLC19A3 antibody |
|||
| FNab07915 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC19A3 |
|||
anti- SLC20A1 antibody |
|||
| FNab07917 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC20A1 |
|||
anti- SLC20A2 antibody |
|||
| FNab07918 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC20A2 |
|||
anti- SLC22A1 antibody |
|||
| FNab07919 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC22A1 |
|||
anti- SLC22A2 antibody |
|||
| FNab07923 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC22A2 |
|||
anti- SLC24A4 antibody |
|||
| FNab07925 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC24A4 |
|||
anti- SLC24A6 antibody |
|||
| FNab07926 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC24A6 |
|||
anti- SLC25A1 antibody |
|||
| FNab07927 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A1 |
|||
anti- SLC25A2 antibody |
|||
| FNab07933 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A2 |
|||
anti- SLC25A3 antibody |
|||
| FNab07939 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A3 |
|||
anti- SLC25A4 antibody |
|||
| FNab07942 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A4 |
|||
anti- SLC25A5 antibody |
|||
| FNab07945 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A5 |
|||
anti- SLC25A6 antibody |
|||
| FNab07946 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC25A6 |
|||
anti- SLC27A2 antibody |
|||
| FNab07948 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC27A2 |
|||
anti- SLC27A3 antibody |
|||
| FNab07949 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC27A3 |
|||
anti- SLC30A6 antibody |
|||
| FNab07950 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC30A6 |
|||
anti- SLC34A2 antibody |
|||
| FNab07952 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC34A2 |
|||
anti- SLC35A1 antibody |
|||
| FNab07953 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC35A1 |
|||
anti- SLC36A4 antibody |
|||
| FNab07955 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC36A4 |
|||
anti- SLC37A1 antibody |
|||
| FNab07956 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC37A1 |
|||
anti- SLC37A2 antibody |
|||
| FNab07957 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC37A2 |
|||
anti- SLC37A4 antibody |
|||
| FNab07958 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC37A4 |
|||
anti- SLC38A1 antibody |
|||
| FNab07959 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC38A1 |
|||
anti- SLC38A3 antibody |
|||
| FNab07960 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC38A3 |
|||
anti- SLC38A4 antibody |
|||
| FNab07961 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC38A4 |
|||
anti- SLC44A1 antibody |
|||
| FNab07964 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC44A1 |
|||
anti- SLC45A2 antibody |
|||
| FNab07965 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC45A2 |
|||
anti- SLC47A1 antibody |
|||
| FNab07966 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC47A1 |
|||
anti- SLC52A3 antibody |
|||
| FNab07969 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against SLC52A3 |
|||
anti- SLC16A7 antibody |
|||
| FNab09923 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC16A7 |
|||
anti- SLC16A7 antibody |
|||
| LSMab09923 | Lifescience Market | 100 ug | EUR 463.2 |
anti- SLC5A11 antibody |
|||
| FNab07970 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC5A11 |
|||
anti- SLC9A11 antibody |
|||
| FNab07975 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC9A11 |
|||
anti- SLC22A18AS antibody |
|||
| FNab07922 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC22A18AS |
|||
SLC52A1 ORF Vector (Human) (pORF) |
|||
| ORF032496 | ABM | 1.0 ug DNA | Ask for price |
anti- SLC1A4 antibody |
|||
| FNab07916 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC1A4 |
|||
anti- SLC3A1 antibody |
|||
| FNab07962 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC3A1 |
|||
anti- SLC4A4 antibody |
|||
| FNab07967 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC4A4 |
|||
anti- SLC4A8 antibody |
|||
| FNab07968 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC4A8 |
|||
anti- SLC5A3 antibody |
|||
| FNab07971 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC5A3 |
|||
anti- SLC5A8 antibody |
|||
| FNab07972 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC5A8 |
|||
anti- SLC6A8 antibody |
|||
| FNab07973 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC6A8 |
|||
anti- SLC7A4 antibody |
|||
| FNab07974 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against SLC7A4 |
|||
anti- SLC9A9 antibody |
|||
| FNab07976 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC9A9 |
|||
anti- SLC4A4 antibody |
|||
| FNab10060 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SLC4A4 |
|||
anti- SLC4A1 antibody |
|||
| FNab10161 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against SLC4A1 |
|||
Human SLC52A1 knockout cell line |
|||
| ABC-KH14151 | AcceGen | 1 vial | Ask for price |
|
Description: Human SLC52A1 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
Human SLC52A1 knockdown cell line |
|||
| ABC-KD14151 | AcceGen | 1 vial | Ask for price |
|
Description: Human SLC52A1 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
Human SLC52A1 Protein Lysate 20ug |
|||
| IHUSLC52A1PLLY20UG | Innovative research | each | EUR 213 |
|
Description: Human SLC52A1 Protein Lysate 20ug |
|||
anti- NAS1/SLC13A1 antibody |
|||
| FNab05558 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against NAS1/SLC13A1 |
|||
OCOA09802-20UG - SLC52A1 Protein Lysate |
|||
| OCOA09802-20UG | Aviva Systems Biology | 20ug | EUR 169 |
OCOA18213-20UG - SLC52A1 Protein Lysate |
|||
| OCOA18213-20UG | Aviva Systems Biology | 20ug | EUR 169 |
Anti-KCC2/SLC12A5 Antibody |
|||
| A04629-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-NAS1/SLC13A1 antibody |
|||
| PAab05558 | Lifescience Market | 100 ug | EUR 463.2 |
Anti-KCC1 / SLC12A4 antibody |
|||
| STJ71332 | St John's Laboratory | 100 µg | EUR 430.8 |
Anti-KCC4 / SLC12A7 antibody |
|||
| STJ71333 | St John's Laboratory | 100 µg | EUR 312 |
Anti-KCC3 / SLC12A6 antibody |
|||
| STJ71334 | St John's Laboratory | 100 µg | EUR 430.8 |
Anti-MCT1/SLC16A1 antibody |
|||
| STJ11100895 | St John's Laboratory | 100 µl | EUR 332.4 |
|
Description: The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene. |
|||
Anti-VMAT1/SLC18A1 Antibody |
|||
| A07692-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-NKCC1/SLC12A2 Antibody |
|||
| PA2169 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-VMAT2 / SLC18A2 antibody |
|||
| STJ70623 | St John's Laboratory | 100 µg | EUR 430.8 |
Anti-NRAMP1/SLC11A1 Antibody |
|||
| A02547-3 | BosterBio | 100ug/vial | EUR 400.8 |
anti- SGLT3/SLC5A4 antibody |
|||
| FNab07810 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SGLT3/SLC5A4 |
|||
Anti-CAT1/SLC7A1 Antibody |
|||
| PA2245 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-LAT1 / SLC7A5 antibody |
|||
| STJ71879 | St John's Laboratory | 100 µg | EUR 430.8 |
Anti-GAT1 / SLC6A1 antibody |
|||
| STJ71938 | St John's Laboratory | 100 µg | EUR 312 |
Anti-GLUT12/SLC2A12 Antibody |
|||
| PA2167 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-GLUT6/SLC2A6 Antibody |
|||
| A11862-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-EAAT1/SLC1A3 Antibody |
|||
| A02133 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-GLUT9/SLC2A9 Antibody |
|||
| A02245 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-SGLT2/SLC5A2 Antibody |
|||
| A03748-1 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-GLUT9/SLC2A9 Antibody |
|||
| PB9891 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-EAAT1/SLC1A3 Antibody |
|||
| PB9959 | BosterBio | 100ug/vial | EUR 400.8 |
Anti-EAAT3/SLC1A1 Antibody |
|||
| PA2164-1 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-EAAT3/SLC1A1 Antibody |
|||
| PA2164-2 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-GLUT9/SLC2A9 Antibody |
|||
| PA2166 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-EAAT1/SLC1A3 Antibody |
|||
| PA2185 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-EAAT4/SLC1A6 Antibody |
|||
| PA2243 | BosterBio | 100ug/vial | EUR 352.8 |
Anti-SGLT1/SLC5A1 Antibody |
|||
| PA2244 | BosterBio | 100ug/vial | EUR 352.8 |